These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 6223045)

  • 21. The influence of androgens on insulin resistance.
    Shoupe D; Lobo RA
    Fertil Steril; 1984 Mar; 41(3):385-8. PubMed ID: 6230259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
    Rubens R
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism.
    Kirschner MA; Samojlik E; Szmal E
    J Clin Endocrinol Metab; 1987 Oct; 65(4):597-601. PubMed ID: 3654909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion.
    Gilad S; Chayen R; Tordjman K; Kisch E; Stern N
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):459-64. PubMed ID: 8187312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of plasma androstenedione to 5 alpha-androstanediol glucuronide in women with idiopathic hirsutism.
    Gompel A; Wright F; Kuttenn F; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1986 Feb; 62(2):441-4. PubMed ID: 3941165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M; Lachinsky N; Moolenaar AJ
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated production and metabolic clearance rates of androgens in morbidly obese women.
    Samojlik E; Kirschner MA; Silber D; Schneider G; Ertel NH
    J Clin Endocrinol Metab; 1984 Nov; 59(5):949-54. PubMed ID: 6480813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
    Horton R; Hawks D; Lobo R
    J Clin Invest; 1982 May; 69(5):1203-6. PubMed ID: 7068855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women.
    Brochu M; Bélanger A; Tremblay RR
    Fertil Steril; 1987 Dec; 48(6):948-53. PubMed ID: 2960564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of androstanediol glucuronide, total testosterone, and free testosterone in hirsute women.
    Khoury MY; Baracat EC; Pardini DP; Vieira JG; de Lima GR
    Fertil Steril; 1994 Jul; 62(1):76-80. PubMed ID: 8005308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical value of 3 alpha-androstanediol-glucuronide in hirsute women].
    Joura EA; Sator MO; Geusau A; Zeisler H; Söregi G; Huber JC
    Wien Klin Wochenschr; 1997 Dec; 109(23):919-21. PubMed ID: 9487606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of 5-androstene-3 beta,17 beta-diol sulphate, 5 alpha-androstane-3 alpha, 17beta-diol sulphate and glucuronide, in late onset 21-hydroxylase deficiency.
    Montalto J; Funder JW; Yong AB; Whorwood CB; Connelly JF
    J Steroid Biochem Mol Biol; 1990 Nov; 37(4):593-8. PubMed ID: 2177625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oestrogen and androgen states in oligo-amenorrhoeic women with polycystic ovaries.
    Fox R; Corrigan E; Thomas PG; Hull MG
    Br J Obstet Gynaecol; 1991 Mar; 98(3):294-9. PubMed ID: 1827032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androsterone sulfate: physiology and clinical significance in hirsute women.
    Zwicker H; Rittmaster RS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum androstanediol glucuronide in women with facial hirsutism.
    Salman K; Spielvogel RL; Shulman LH; Miller JL; Vanderlinde RE; Rose LI
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):411-4. PubMed ID: 1564146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in plasma 5 alpha-androstane-3 alpha,17 beta-diol glucuronide as a marker of peripheral androgen action in hirsutism: a side-effect induced by cyclosporine A.
    Vexiau P; Fiet J; Boudou P; Villette JM; Feutren G; Hardy N; Julien R; Dreux C; Bach JF; Cathelineau G
    J Steroid Biochem; 1990 Jan; 35(1):133-7. PubMed ID: 2137888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of androgen measurements in polycystic ovary syndrome.
    Raj SG; Thompson IE; Berger MJ; Talert LM; Taymor ML
    Obstet Gynecol; 1978 Aug; 52(2):169-71. PubMed ID: 567313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia.
    Montalto J; Whorwood CB; Funder JW; Yong AB; Callan A; Davies HE; Connelly JF
    Clin Endocrinol (Oxf); 1990 Jan; 32(1):1-12. PubMed ID: 2139595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.